Position in LQDA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$103,649
New position
Shares Held
1,300
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#272
of 334 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $2,658,245 across 7 Drug Manufacturers - Specialty & Generic names. LQDA ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
34,881 | $1,181,768 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
6,015 | $667,304 | |
| 3 | ALKS |
Alkermes plc.
|
5,811 | $304,496 | |
| 4 | ZTS |
Zoetis Inc.
|
2,510 | $180,368 | |
| 5 | TRLV |
Trulieve Cannabis Corp.
|
16,592 | $163,099 | |
| 6 | LQDA |
Liquidia Corp
This page
|
1,300 | $103,649 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
12,820 | $57,561 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,649 | 1,300 | Shares | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||